chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 90.0
Sex: M
Vaccine: COVID19
Symptoms: Blood lactic acid increased, Blood potassium increased, Blood urea increased, Death, Electrocardiogram abnormal
Clinical narrative: 2/24/21 Patient Died.  02/23/21. Patient came to ED for weakness/falls. Patient had fallen on 02/21 and 02/23. UA was done in LTC, and he was started on ciprofloxacin 02/22/21. Treatment was to put patient on comfort cares (morphine + lorazepam)
Age: 90.0
Sex: M
Vaccine: COVID19
Symptoms: Fall, Procalcitonin increased, SARS-CoV-2 test negative, Troponin normal, Urine analysis
Clinical narrative: 2/24/21 Patient Died.  02/23/21. Patient came to ED for weakness/falls. Patient had fallen on 02/21 and 02/23. UA was done in LTC, and he was started on ciprofloxacin 02/22/21. Treatment was to put patient on comfort cares (morphine + lorazepam)
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Eye pain, Facial pain, Oral pain, Oropharyngeal pain, Sinusitis
Clinical narrative: Left side of face pain including eye inside mouth and throat. Felt like bad sinus infection. Still have some throat pain
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia oral
Clinical narrative: numbing around the lips shortly after administration of Moderna Vaccine. symptoms resolved within 1/2 hour and patient left
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Interchange of vaccine products
Clinical narrative: The patient received the COVID vaccine for the second dose instead of the COVID vaccine.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Dyspnoea, Fatigue, Lymphocytosis, Neutropenia
Clinical narrative: absolute neutropenia, relative lymphocytosis, normocytic anemia and a typical monocular cells; Increasing fatigue and shortness of breath; Increasing fatigue and shortness of breath; absolute neutropenia, relative lymphocytosis, normocytic anemia and a typical monocular cells; absolute neutropenia, relative lymphocytosis, normocytic anemia and a typical monocular cells; This is a spontaneous report from a health care professional, the patient.  A 75-years-old non-pregnant female patient  received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot Number: EN5318), via an unspecified route of administration from in the right  arm on 29Jan2021 at 13:30 (at the age of 75-years-old) as a single dose, for COVID-19 vaccination.  Medical history included heart valve replacement (under the care of cardiologist for heart valve leakage  causing some shortness of breath &  fatigue, but was manageable), thyroid cancer, breast cancer female and tricuspid valve disease. Patient did receive concomitant medications in two weeks but details were not provided. The patient previously took penicilin and experienced drug hypersensitivity.. No other vaccines were given within 4 weeks.  Since the vaccination the patient had not been tested for COVID-19. Prior to vaccination, the patient was not diagnosed with COVID-19. On 01Feb2021 at 12:00, The patient experienced  absolute neutropenia (medically significant)   and  relative lymphocytosis, normocytic anemia and a typical monocular cells, and increasing fatigue and shortness of breath (in 2 weeks since vaccine on 29Jan2021; almost debilitating). The patient underwent lab tests included Blood test 4 months earlier results were normal on an unspecified date, Blood Test during routine check-up on 02Jan2021, revealed absolute neutropenia, relative lymphocytosis, normocytic anemia and a typical monocular cells. . No treatment was given for the events. Consumer inquired if the  vaccine can contribute to increase in fatigue and shortness of breath and new blood work reading. The clinical outcome of the events absolute neutropenia, lymphocytosis, normocytic anemia and a typical monocular cells,  and increasing fatigue and shortness of breath was not recovered.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Normocytic anaemia
Clinical narrative: absolute neutropenia, relative lymphocytosis, normocytic anemia and a typical monocular cells; Increasing fatigue and shortness of breath; Increasing fatigue and shortness of breath; absolute neutropenia, relative lymphocytosis, normocytic anemia and a typical monocular cells; absolute neutropenia, relative lymphocytosis, normocytic anemia and a typical monocular cells; This is a spontaneous report from a health care professional, the patient.  A 75-years-old non-pregnant female patient  received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot Number: EN5318), via an unspecified route of administration from in the right  arm on 29Jan2021 at 13:30 (at the age of 75-years-old) as a single dose, for COVID-19 vaccination.  Medical history included heart valve replacement (under the care of cardiologist for heart valve leakage  causing some shortness of breath &  fatigue, but was manageable), thyroid cancer, breast cancer female and tricuspid valve disease. Patient did receive concomitant medications in two weeks but details were not provided. The patient previously took penicilin and experienced drug hypersensitivity.. No other vaccines were given within 4 weeks.  Since the vaccination the patient had not been tested for COVID-19. Prior to vaccination, the patient was not diagnosed with COVID-19. On 01Feb2021 at 12:00, The patient experienced  absolute neutropenia (medically significant)   and  relative lymphocytosis, normocytic anemia and a typical monocular cells, and increasing fatigue and shortness of breath (in 2 weeks since vaccine on 29Jan2021; almost debilitating). The patient underwent lab tests included Blood test 4 months earlier results were normal on an unspecified date, Blood Test during routine check-up on 02Jan2021, revealed absolute neutropenia, relative lymphocytosis, normocytic anemia and a typical monocular cells. . No treatment was given for the events. Consumer inquired if the  vaccine can contribute to increase in fatigue and shortness of breath and new blood work reading. The clinical outcome of the events absolute neutropenia, lymphocytosis, normocytic anemia and a typical monocular cells,  and increasing fatigue and shortness of breath was not recovered.
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Injection site erythema, Injection site pain, Injection site rash, Injection site swelling, Injection site warmth
Clinical narrative: Per Client received first COVID 19 vaccine in left deltoid on 2/1/2021 and had mild discomfort at site for one day. Received second COVID 19 vaccine in left deltoid on 2/22/2025 and next day notice a reaction. Per Client left arm, vaccine site was hot to touch, tender, red raised whelps and swollen. Per Client left arm is still with all the previous descriptions. Per Client did take Tylenol for tenderness and has not seek any medical attention. Client also report to receiving both vaccines in left arm only due to already existing complication with right arm. Writer suggested that Client follow up with PCP and continue to monitor left arm, client verbalized plan to follow up with PCP or emergency attention if needed.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Vomiting
Clinical narrative: severe vomiting and diarrhea lasting 8-10 hours
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Lymphadenopathy
Clinical narrative: Redness at site; 7cm circular of erythema, palpable axillary lymph node  Doubt infection Instructed to monitor, hot compresses
Age: 33.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Palpitations
Clinical narrative: Woke up at 2 am with a racing heart rate that lasted 20 mins
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Chills
Clinical narrative: One and a half days after the injection, I had severe chills for about 5 hours. Chills started on Feb. 15 around 2 am and stopped around 7am.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Induration, Limb mass, Pruritus, Skin warm, Tenderness
Clinical narrative: The first week itching and a hard lump, painful to touch Feb 25,2021 itching started again, larger lump reappeared, very warm to touch, 4 inch red circle
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Fatigue, Pain in extremity, Pyrexia
Clinical narrative: right arm is sore; Fever; tired; This is a spontaneous report from a contactable Nurse (patient).  An 89-year-old female patient received the 2nd dose of bnt162b2 (BNT162B2, Batch/lot # EM9809, Exp date 30Jun2021) intramuscular at single dose in right upper arm on 11Feb2021 16:24 for Covid-19 immunisation, administered at hospital.  Medical history included ongoing chronic obstructive pulmonary disease (COPD) and ongoing arthritis both diagnosed about 5 or 6 years before, covid-19 and pneumonia in Nov2020 and she was in the hospital from 04Nov2020 to 09Nov2020, she was hard of hearing. There were no concomitant medications. The patient received no prior vaccinations (within 4 weeks), aside the 1st dose of bnt162b2 (BNT162B2, Lot: EL9261, Exp date 31May2021) intramuscular at single dose in right upper arm on 21Jan2021 16:24 for Covid-19 immunisation. No additional vaccines administered on same date of BNT162B2. No events occurred following prior vaccinations. The patient experienced right arm is sore, fever, tired on 12Feb2021. The events were considered medically significant. No event required a visit to Emergency Room or physician. No relevant test done. Course of events as follows: Her arm was sore. Sore arm started on 12Feb2021 morning. She has arthritis and stated maybe this had something to with the soreness in upper right arm, near shoulder, where the vaccine was administered about an inch below her shoulder. Soreness was just there, it hurt. She was very tired and running a temperature of 100.4. She noticed the fever when she got up on 12Feb2021 morning, it was only 99.3 or 99 something, in afternoon it was 100.4. She did not like the fever. She took of paracetamol (TYLENOL 500mg, Lot: 9HV1619, Expiration date May2021) 1000mg twice and it did not really take her fever down. The outcome of events was not recovered.  The reporter considered there was a reasonable possibility that the events right arm is sore, fever, tired were related to the BNT162B2.; Sender's Comments: Based on information available, a acausal relationship between events right arm is sore, fever and tiredness and BNT162B2 vaccine cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
Age: 45.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Dizziness, Dyspnoea, Headache, Injection site rash
Clinical narrative: Moderna COVID-19 EUA. Severe headache, chills, nausea, dizziness, shortness of breath, and rash where I was injected
Age: 45.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Nausea
Clinical narrative: Moderna COVID-19 EUA. Severe headache, chills, nausea, dizziness, shortness of breath, and rash where I was injected
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: Mbr developed dizziness about an hour after receiving vaccination and was evaluated..  Vital signs and physical exam were all unremarkable.  Negative for any other sxs.  Negative for any neurological abnormalities on exam.  No cognitive deficits.   She was sent home to rest and hydrate with ED precautions.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature increased, Fatigue, Nausea
Clinical narrative: At 8 PM last night, 2/25/2021 patient began to feel nauseous and fatigued.  This morning the symtoms were more pronounced and at 8:45AM she had a temperature of 100.4.  She ate a piece of buttered toast and was drinking water.  Both stayed down.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Pain, Pyrexia
Clinical narrative: Fever, chills, body aches, headache.
Sex: U
Vaccine: FLUX
Symptoms: Malaise
Clinical narrative: sicker; Initial information was received on 16-Feb-2021 regarding an unsolicited valid non-serious case received from a consumer or Non-health care professional.  This case involves a patient (unknown age and unknown gender) who experienced sickness (illness), while he/she received vaccine INFLUENZA VACCINE.  Medical history, medical treatment(s), vaccination(s), concomitant medications and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE (produced by unknown manufacturer) [lot number not reported and expiry date not provided] via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed a non-serious event sickness (illness) (unknown latency) following the administration of INFLUENZA VACCINE.  Details of laboratory data were not reported.  It was not reported if the patient received any corrective treatment.  The patient reported that got one once and was sicker that year than he/she ever was with the flu, haven't been sick with the flu since he/she stopped drinking almost 4 years ago. It is unknown if the patient physician provided consent to be contacted. It is unknown if the patient experienced any additional symptoms/events.   At the time of report, the outcome of event was unknown.  There will be no information available on batch number for this case.
Age: 93.0
Sex: F
Vaccine: COVID19
Symptoms: Balance disorder, Feeling drunk, Gait disturbance
Clinical narrative: Felt as if drunk, off balance, had to hold furniture to walk, lasted into 2nd day. No fever or soreness.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Influenza, Somnolence
Clinical narrative: Worst flu ever symptoms. Chills; fatigue: sleepiness,
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Dysphagia, Dyspnoea, Urticaria
Clinical narrative: The individual came in for their second dose of the Moderna vaccine.  Approximately 10 minutes after vaccination she started to rub her chest and reported mild tightness which resolved quickly.  She was monitored by a nurse for an additional 15 minutes for a total of thirty minutes.  She reported the next day that approximately and hour after vaccinations she began to experience difficulty swallowing.  She self administered her prescribed inhalers and took liquid diphenhydramine .  She reports hives and dyspnea that resolved by the following day.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Chills, Flushing, Headache, Musculoskeletal stiffness
Clinical narrative: WITHIN THREE HOURS AFTER VAX, FACE BECAME REALLY FLUSHED, WOKE UP AT 2AM WITH SEVERE CHILLS, BODY & JOINT ACHES AND STIFF NECK ALONG WITH POUNDING HEADACHE.
Age: 82.0
Sex: F
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: WITHIN THREE HOURS AFTER VAX, FACE BECAME REALLY FLUSHED, WOKE UP AT 2AM WITH SEVERE CHILLS, BODY & JOINT ACHES AND STIFF NECK ALONG WITH POUNDING HEADACHE.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Accelerated hypertension, Atelectasis, Blood sodium normal, Blood thyroid stimulating hormone normal, Chest X-ray normal
Clinical narrative: The day following Moderna #2 (on 2/17/21) she had sudden onset of confusion.  She thought the remote control was the telephone and speech was confused.  No motor deficits.  Was taken to ER and then admitted to Medical Center for stroke-like symptoms.  Admitted 2/18/21, discharged 2/20/21 with diagnosis of Acute Encephalopathy (possible TIA) and Accelerated hypertension.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Computerised tomogram head, Confusional state, Differential white blood cell count normal, Encephalopathy, Hypokalaemia
Clinical narrative: The day following Moderna #2 (on 2/17/21) she had sudden onset of confusion.  She thought the remote control was the telephone and speech was confused.  No motor deficits.  Was taken to ER and then admitted to Medical Center for stroke-like symptoms.  Admitted 2/18/21, discharged 2/20/21 with diagnosis of Acute Encephalopathy (possible TIA) and Accelerated hypertension.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Magnetic resonance imaging brain abnormal, Neurological symptom, SARS-CoV-2 test negative, Speech disorder, Ultrasound Doppler
Clinical narrative: The day following Moderna #2 (on 2/17/21) she had sudden onset of confusion.  She thought the remote control was the telephone and speech was confused.  No motor deficits.  Was taken to ER and then admitted to Medical Center for stroke-like symptoms.  Admitted 2/18/21, discharged 2/20/21 with diagnosis of Acute Encephalopathy (possible TIA) and Accelerated hypertension.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Urine analysis normal, White blood cell count normal
Clinical narrative: The day following Moderna #2 (on 2/17/21) she had sudden onset of confusion.  She thought the remote control was the telephone and speech was confused.  No motor deficits.  Was taken to ER and then admitted to Medical Center for stroke-like symptoms.  Admitted 2/18/21, discharged 2/20/21 with diagnosis of Acute Encephalopathy (possible TIA) and Accelerated hypertension.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Blood lactic acid increased, Dyspnoea, Immunoglobulin therapy, Lactic acidosis, Lung infiltration
Clinical narrative: Shortness of breath and respiratory distress resulting in mechanical ventilation. Some concern for myasthenia crisis due to presentation, started on course of IVIG.  Possible azithromycin (home medication) could have been contributing to this as well.  Also in septic shock with extensive lung infiltrates started on broad spectrum antibiotics with vancomycin and Zosyn - Zosyn was transitioned to cefepime. Lactic acidosis secondary to shock (initially 7.2 which has trended down to 2.5 at time of submission).
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Mechanical ventilation, Myasthenia gravis crisis, Respiratory distress, Septic shock
Clinical narrative: Shortness of breath and respiratory distress resulting in mechanical ventilation. Some concern for myasthenia crisis due to presentation, started on course of IVIG.  Possible azithromycin (home medication) could have been contributing to this as well.  Also in septic shock with extensive lung infiltrates started on broad spectrum antibiotics with vancomycin and Zosyn - Zosyn was transitioned to cefepime. Lactic acidosis secondary to shock (initially 7.2 which has trended down to 2.5 at time of submission).
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Raynaud's phenomenon
Clinical narrative: Raynaud?s left fingers 2-5
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Injection site erythema, Injection site pain, Injection site reaction, Pain
Clinical narrative: Pt received vaccination on Friday.  On Friday evening she started to run a fever, but Sat am she reports temp of 102, chills, body aches, sore/red vaccination site.  Presented to ER.  Rapid COVID test negative.  Determined to be vaccination reaction.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test negative
Clinical narrative: Pt received vaccination on Friday.  On Friday evening she started to run a fever, but Sat am she reports temp of 102, chills, body aches, sore/red vaccination site.  Presented to ER.  Rapid COVID test negative.  Determined to be vaccination reaction.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Dysgeusia, Feeling hot
Clinical narrative: APPROXIMATELY 10 MINUTES AFGER RECEIVING DOSE, PATIENT COMPLAINED OF "WEIRD METALLIC TASTE AND GETTING REALLY HOT" THAT ONLY LASTED A COUPLE MINUTES AND THEN WENT AWAY. .  DENIED ANY OTHER SYMPTOMS.  NO TREATMENT REQUIRED
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Pain
Clinical narrative: Shooting-sharp pains  above the L elbow lateral/posterior ; lasts a few minutes then subsides. Not aggregated with movement nor relief with repostioning. Occurs randomly several times through the day.
Age: 30.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Nausea, Pharyngeal swelling
Clinical narrative: Vaccine administered 9:10am and reaction began around 09:15am with throat swelling, nausea and dizzy after 5 mins. Had some improvement with observation at 15 mins, vitals remained stable. Patient was able to drink water although continued to have throat swelling after 30 mins of observation. EMS arrived at 35 minutes and determined stable, asked for non-emergent ambulance to be called for transfer. Patient transferred per guidelines via EMS to Hospital approximately 10:15am.
Age: 30.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Body temperature, Dizziness, Dyspnoea, Hyperhidrosis, Nausea
Clinical narrative: Vaccine administered 9:10am and reaction began around 09:15am with throat swelling, nausea and dizzy after 5 mins. Had some improvement with observation at 15 mins, vitals remained stable. Patient was able to drink water although continued to have throat swelling after 30 mins of observation. EMS arrived at 35 minutes and determined stable, asked for non-emergent ambulance to be called for transfer. Patient transferred per guidelines via EMS to Hospital approximately 10:15am.
Age: 30.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Oxygen saturation, Throat tightness
Clinical narrative: Vaccine administered 9:10am and reaction began around 09:15am with throat swelling, nausea and dizzy after 5 mins. Had some improvement with observation at 15 mins, vitals remained stable. Patient was able to drink water although continued to have throat swelling after 30 mins of observation. EMS arrived at 35 minutes and determined stable, asked for non-emergent ambulance to be called for transfer. Patient transferred per guidelines via EMS to Hospital approximately 10:15am.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Asthenia, Hypoxia, Pleural effusion, Pneumonia
Clinical narrative: 1st dose vaccine 2/21/21; developed weakness and went to ED via EMS on 2/26/21 and admitted to Hospital from ED DX: Acute respiratory failure with hypoxia ; Pleural effusion, left; Community acquired pneumonia of right lung, unspecified part of lung   currently admitted to hospital during time of this report.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Blood pressure increased, Chest discomfort, Disturbance in attention, Dizziness
Clinical narrative: Following the vaccine, within 3 minutes her bottom lip got numb, then her tongue swelled and then her eyes got fluttery uncontrollably, dizziness and weak.  They had her lie down in a recliner.  Her BP was 190/110.  She did not need an EPI pen and within 15 minutes her lip became unnumb, and her tongue swelling receded, was still a little thick, and her face was swollen, was red and flushed.  So they waited 30 minutes, her BP was not coming down, sent to the ER and observed for 3 hours and slowly her BP came down, all her other symptoms subsided and she was able to drive herself home.  Last night 2/25/21 she had great itching on her chest, which has since stopped.  Her tongue is still a little swollen, about 20% still feels thick.  When she left the hospital her BP was 146/86.  She has not taken anything for the symptoms just her regular routine medications.   She did feel tired and spacy feeling, and has been off of work since Wednesday as she could not focus to go to work.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Eye movement disorder, Fatigue, Feeling abnormal, Flushing
Clinical narrative: Following the vaccine, within 3 minutes her bottom lip got numb, then her tongue swelled and then her eyes got fluttery uncontrollably, dizziness and weak.  They had her lie down in a recliner.  Her BP was 190/110.  She did not need an EPI pen and within 15 minutes her lip became unnumb, and her tongue swelling receded, was still a little thick, and her face was swollen, was red and flushed.  So they waited 30 minutes, her BP was not coming down, sent to the ER and observed for 3 hours and slowly her BP came down, all her other symptoms subsided and she was able to drive herself home.  Last night 2/25/21 she had great itching on her chest, which has since stopped.  Her tongue is still a little swollen, about 20% still feels thick.  When she left the hospital her BP was 146/86.  She has not taken anything for the symptoms just her regular routine medications.   She did feel tired and spacy feeling, and has been off of work since Wednesday as she could not focus to go to work.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia oral, Immediate post-injection reaction, Impaired work ability, Swelling face, Swollen tongue
Clinical narrative: Following the vaccine, within 3 minutes her bottom lip got numb, then her tongue swelled and then her eyes got fluttery uncontrollably, dizziness and weak.  They had her lie down in a recliner.  Her BP was 190/110.  She did not need an EPI pen and within 15 minutes her lip became unnumb, and her tongue swelling receded, was still a little thick, and her face was swollen, was red and flushed.  So they waited 30 minutes, her BP was not coming down, sent to the ER and observed for 3 hours and slowly her BP came down, all her other symptoms subsided and she was able to drive herself home.  Last night 2/25/21 she had great itching on her chest, which has since stopped.  Her tongue is still a little swollen, about 20% still feels thick.  When she left the hospital her BP was 146/86.  She has not taken anything for the symptoms just her regular routine medications.   She did feel tired and spacy feeling, and has been off of work since Wednesday as she could not focus to go to work.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Tongue disorder
Clinical narrative: Following the vaccine, within 3 minutes her bottom lip got numb, then her tongue swelled and then her eyes got fluttery uncontrollably, dizziness and weak.  They had her lie down in a recliner.  Her BP was 190/110.  She did not need an EPI pen and within 15 minutes her lip became unnumb, and her tongue swelling receded, was still a little thick, and her face was swollen, was red and flushed.  So they waited 30 minutes, her BP was not coming down, sent to the ER and observed for 3 hours and slowly her BP came down, all her other symptoms subsided and she was able to drive herself home.  Last night 2/25/21 she had great itching on her chest, which has since stopped.  Her tongue is still a little swollen, about 20% still feels thick.  When she left the hospital her BP was 146/86.  She has not taken anything for the symptoms just her regular routine medications.   She did feel tired and spacy feeling, and has been off of work since Wednesday as she could not focus to go to work.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Sensitive skin, Urticaria
Clinical narrative: I received my first injection of the COVID-19 vaccine on 12/28/2020 and the second dose on 01/12/2021. Starting  Friday February 5, I developed severe itching on my back that occurred during sleep only. The itching continued for the next several nights. I had to remove my bra in order to obtain any sleep. After removing the bra, the itching eventually stopped. I tried several bras, but all caused itching at bedtime only. Now, itching is occurring on other parts of my body. Hives and itching have developed on my back, chest, inner thighs and both hands. The itching is relieved by applying lotion. My skin is super sensitive to elastics (in most bras) and other items. I'm only reporting this just in case other people have experienced the same sensitivities. I don't believe the vaccine caused the itching and hives; but instead just hastened or exacerbated something already in my body.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Incorrect route of product administration, Infection
Clinical narrative: Lot EN6203 .3 ml Table #3  Both the pharmacist and her own physician said that the vaccine was given too close to her elbow-- not intramuscularly; Dr. is treating for infection;
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site pain, Injection site pruritus, Injection site swelling, Injection site warmth
Clinical narrative: red, hot, swollen, painful and itchy patch left arm surrounding injection site. Prednisone 20 mg daily on 2/22/2021   and Keflex 500 mg TID and 2/23/2021.  Neither helped.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Allergy to vaccine, Chest X-ray normal, Chest discomfort, Dysphonia, Pruritus
Clinical narrative: 47yo obese female h/o Asthma ambulated into the ED c/o severe allergy to the Moderna Vaccine which she received 40minutes ago. Patient state, she was advise about the risk and side effects of the vaccine. Patient state, she noticed nothing initial, then suddenly chest tightness, itching to the face, hoarseness, and wheezing. Patient state, she called the hotline for advise and advise to use her asthma inhaler and go to the nearest ED. Patient state, she received 40 of prednisone prior to receiving the Moderna vaccine in the left arm.  47yo female is in no acute distress. Patient symptoms resolving. Patient has no hoarseness or difficulty swallowing. Patient has no itchiness or respiratory distress. Patient chest xray shows no acute findings. Patient will continue with medication as prescribed. patient will be discharge home.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Wheezing
Clinical narrative: 47yo obese female h/o Asthma ambulated into the ED c/o severe allergy to the Moderna Vaccine which she received 40minutes ago. Patient state, she was advise about the risk and side effects of the vaccine. Patient state, she noticed nothing initial, then suddenly chest tightness, itching to the face, hoarseness, and wheezing. Patient state, she called the hotline for advise and advise to use her asthma inhaler and go to the nearest ED. Patient state, she received 40 of prednisone prior to receiving the Moderna vaccine in the left arm.  47yo female is in no acute distress. Patient symptoms resolving. Patient has no hoarseness or difficulty swallowing. Patient has no itchiness or respiratory distress. Patient chest xray shows no acute findings. Patient will continue with medication as prescribed. patient will be discharge home.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Headache, Nausea, Pain
Clinical narrative: Chills, fatigue, body aches, headache, fever, nausea  Took Tylenol after 24 hours Helped lessen the symptoms. Took more Tylenol after 6 more hours.  48 hours later-am 70% improved.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Chills, fatigue, body aches, headache, fever, nausea  Took Tylenol after 24 hours Helped lessen the symptoms. Took more Tylenol after 6 more hours.  48 hours later-am 70% improved.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Injection site hypertrophy, Pain in extremity, Skin warm
Clinical narrative: WITHIN THE FIRST HOUR PATIENT NOTICED HER ARM WAS HOT  AND RED.  THAT NIGHT ARM HURT ALL THE WAY TO HER FINGERS.  ARM IS STILL RED AND HOT TO TOUCH.  ALSO A QUARTER SIZED THICKNESS AT INJECTION SITE
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Maternal exposure during pregnancy, Pyrexia
Clinical narrative: Low grade fever (100.2) and headache; pregnant at time of vaccination, due date 3/27/2021
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site induration, Injection site nodule, Injection site pain, Injection site pruritus
Clinical narrative: Abt 2 hrs after receiving the injection my arm became very sore (which I thought was normal) & continued to worsen, The next day after the shot 2/23 it felt like it had a hard knot in it  & continued to be sore. On the 24th in the evening, it felt like my shirt was to tight & started to . When I looked at my arm it was red, raised and felt hot around the injection site (the area was about 5 or 6 inches long and maybe 2-3 inches across)  When I googled the symptoms & saw pictures, it seemed to resemble "covid arm" I applied a topical steriod that evening & next day and today 2/26 the redness, itchiness is almost gone
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site swelling, Injection site warmth, Pain in extremity
Clinical narrative: Abt 2 hrs after receiving the injection my arm became very sore (which I thought was normal) & continued to worsen, The next day after the shot 2/23 it felt like it had a hard knot in it  & continued to be sore. On the 24th in the evening, it felt like my shirt was to tight & started to . When I looked at my arm it was red, raised and felt hot around the injection site (the area was about 5 or 6 inches long and maybe 2-3 inches across)  When I googled the symptoms & saw pictures, it seemed to resemble "covid arm" I applied a topical steriod that evening & next day and today 2/26 the redness, itchiness is almost gone
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Paraesthesia
Clinical narrative: Some numbness and tingling in arm and fingers. Not constant but noticed in certain positions. Numbness in tip of index finger. Symptoms are improving but have not yet completely resolved. believes "a nerve was nicked" and expects it to heal slowly. She has not reached out to a doctor or clinic; I recommended that she call her health care provider.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Axillary pain, Dizziness, Lymphadenopathy, Pyrexia
Clinical narrative: Highest  fever of 107 but hovers around 103 with Tylenol.  Pain in joints from head to toes. Swollen armpit,like a golf ball and it is very painful. Vomiting and hard to keep anything in including .Tylenol and pain killer oxy 10 mg. I'm really dizzy but my fever has moved back down to 103 , these symptoms are still about 38 hours after the 2nd vaccine.
Age: 44.0
Sex: F
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: Highest  fever of 107 but hovers around 103 with Tylenol.  Pain in joints from head to toes. Swollen armpit,like a golf ball and it is very painful. Vomiting and hard to keep anything in including .Tylenol and pain killer oxy 10 mg. I'm really dizzy but my fever has moved back down to 103 , these symptoms are still about 38 hours after the 2nd vaccine.
Age: 36.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Nausea, Rash
Clinical narrative: Rash beginning from first dose, increasing after second. Covering torso area. Some nausea day 2 after dose 2
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Peripheral swelling
Clinical narrative: Patient reported swelling and redness that spread around the arm.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site inflammation, Injection site pruritus
Clinical narrative: Nine days after receiving the vaccine, my upper right arm  became very itchy and inflamed.  The redness covered most of the upper arm centered around the injection site.   The itchiness and redness slowly dissipated over the course of several days.  6 days later the arm was back to normal.  I did not seek any medical attention for this occurrence.   I am reporting this only because  it was a very unusual  occurrence for me as I have never had any  such reaction to any vaccination received in my life.
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Alanine aminotransferase decreased, Aspartate aminotransferase decreased, Blood creatine phosphokinase, Blood lactate dehydrogenase increased, Cholecystectomy
Clinical narrative: Received COVID vaccine 1 on 1/13 and COVID vaccine #2 2/1.  49 y/o previously healthy female who had a COVID 19 exposure ~ 1/3. The person she was exposed to tested positive 1/6 (daughter had a fever and cough). On 1/11 the patient received the 1st dose of the Pfizer vaccine. 12-24 hours after the Pfizer vaccine she developed fevers, malaise, myalgias that lasted 2-3 days (Called off work). She then returned to a normal state of health. On 2/1 she received the second dose of the vaccine. On 2/6 she developed right pleuritic chest pain so went to an urgent care. COVID 19 PCR was positive and CXR unremarkable. She was told to take naproxen and her pleuritic chest pain slowly improved. On 2/8 she started to have general malaise followed by nausea. On 2/11 she developed increased nausea and vomiting followed by diarrhea-eventually that day she had a near syncopal episode prompting her presentation to the hospital. Seen at an outside hospital between 2/11-2/12. CT abd/pelvis showed patchy ground glass opacities at the base of the lungs and she was noted to have diffuse mural thickening. There was concern for possible cholecystitis so a perc cholecystostomy tube was placed. Ultimately she developed significant hypoxic respiratory failure and had to be intubated.She was transferred to another hospital on 2/12. Initially she was started on treatment with dexamethasone but continued to clinically get worse. Also on empiric antibiotics.
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Computerised tomogram abnormal, Condition aggravated, Diarrhoea, Ejection fraction decreased, Endotracheal intubation
Clinical narrative: Received COVID vaccine 1 on 1/13 and COVID vaccine #2 2/1.  49 y/o previously healthy female who had a COVID 19 exposure ~ 1/3. The person she was exposed to tested positive 1/6 (daughter had a fever and cough). On 1/11 the patient received the 1st dose of the Pfizer vaccine. 12-24 hours after the Pfizer vaccine she developed fevers, malaise, myalgias that lasted 2-3 days (Called off work). She then returned to a normal state of health. On 2/1 she received the second dose of the vaccine. On 2/6 she developed right pleuritic chest pain so went to an urgent care. COVID 19 PCR was positive and CXR unremarkable. She was told to take naproxen and her pleuritic chest pain slowly improved. On 2/8 she started to have general malaise followed by nausea. On 2/11 she developed increased nausea and vomiting followed by diarrhea-eventually that day she had a near syncopal episode prompting her presentation to the hospital. Seen at an outside hospital between 2/11-2/12. CT abd/pelvis showed patchy ground glass opacities at the base of the lungs and she was noted to have diffuse mural thickening. There was concern for possible cholecystitis so a perc cholecystostomy tube was placed. Ultimately she developed significant hypoxic respiratory failure and had to be intubated.She was transferred to another hospital on 2/12. Initially she was started on treatment with dexamethasone but continued to clinically get worse. Also on empiric antibiotics.
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Inflammatory marker increased, Liver function test abnormal, Lung opacity, Malaise, Myalgia
Clinical narrative: Received COVID vaccine 1 on 1/13 and COVID vaccine #2 2/1.  49 y/o previously healthy female who had a COVID 19 exposure ~ 1/3. The person she was exposed to tested positive 1/6 (daughter had a fever and cough). On 1/11 the patient received the 1st dose of the Pfizer vaccine. 12-24 hours after the Pfizer vaccine she developed fevers, malaise, myalgias that lasted 2-3 days (Called off work). She then returned to a normal state of health. On 2/1 she received the second dose of the vaccine. On 2/6 she developed right pleuritic chest pain so went to an urgent care. COVID 19 PCR was positive and CXR unremarkable. She was told to take naproxen and her pleuritic chest pain slowly improved. On 2/8 she started to have general malaise followed by nausea. On 2/11 she developed increased nausea and vomiting followed by diarrhea-eventually that day she had a near syncopal episode prompting her presentation to the hospital. Seen at an outside hospital between 2/11-2/12. CT abd/pelvis showed patchy ground glass opacities at the base of the lungs and she was noted to have diffuse mural thickening. There was concern for possible cholecystitis so a perc cholecystostomy tube was placed. Ultimately she developed significant hypoxic respiratory failure and had to be intubated.She was transferred to another hospital on 2/12. Initially she was started on treatment with dexamethasone but continued to clinically get worse. Also on empiric antibiotics.
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Nausea, Platelet count decreased, Pleuritic pain, Procalcitonin, Procalcitonin increased
Clinical narrative: Received COVID vaccine 1 on 1/13 and COVID vaccine #2 2/1.  49 y/o previously healthy female who had a COVID 19 exposure ~ 1/3. The person she was exposed to tested positive 1/6 (daughter had a fever and cough). On 1/11 the patient received the 1st dose of the Pfizer vaccine. 12-24 hours after the Pfizer vaccine she developed fevers, malaise, myalgias that lasted 2-3 days (Called off work). She then returned to a normal state of health. On 2/1 she received the second dose of the vaccine. On 2/6 she developed right pleuritic chest pain so went to an urgent care. COVID 19 PCR was positive and CXR unremarkable. She was told to take naproxen and her pleuritic chest pain slowly improved. On 2/8 she started to have general malaise followed by nausea. On 2/11 she developed increased nausea and vomiting followed by diarrhea-eventually that day she had a near syncopal episode prompting her presentation to the hospital. Seen at an outside hospital between 2/11-2/12. CT abd/pelvis showed patchy ground glass opacities at the base of the lungs and she was noted to have diffuse mural thickening. There was concern for possible cholecystitis so a perc cholecystostomy tube was placed. Ultimately she developed significant hypoxic respiratory failure and had to be intubated.She was transferred to another hospital on 2/12. Initially she was started on treatment with dexamethasone but continued to clinically get worse. Also on empiric antibiotics.
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pyrexia, Respiratory failure, SARS-CoV-2 test negative, Serum ferritin increased, Syncope
Clinical narrative: Received COVID vaccine 1 on 1/13 and COVID vaccine #2 2/1.  49 y/o previously healthy female who had a COVID 19 exposure ~ 1/3. The person she was exposed to tested positive 1/6 (daughter had a fever and cough). On 1/11 the patient received the 1st dose of the Pfizer vaccine. 12-24 hours after the Pfizer vaccine she developed fevers, malaise, myalgias that lasted 2-3 days (Called off work). She then returned to a normal state of health. On 2/1 she received the second dose of the vaccine. On 2/6 she developed right pleuritic chest pain so went to an urgent care. COVID 19 PCR was positive and CXR unremarkable. She was told to take naproxen and her pleuritic chest pain slowly improved. On 2/8 she started to have general malaise followed by nausea. On 2/11 she developed increased nausea and vomiting followed by diarrhea-eventually that day she had a near syncopal episode prompting her presentation to the hospital. Seen at an outside hospital between 2/11-2/12. CT abd/pelvis showed patchy ground glass opacities at the base of the lungs and she was noted to have diffuse mural thickening. There was concern for possible cholecystitis so a perc cholecystostomy tube was placed. Ultimately she developed significant hypoxic respiratory failure and had to be intubated.She was transferred to another hospital on 2/12. Initially she was started on treatment with dexamethasone but continued to clinically get worse. Also on empiric antibiotics.
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Thrombocytopenia, Troponin I increased, Vomiting, White blood cell count decreased
Clinical narrative: Received COVID vaccine 1 on 1/13 and COVID vaccine #2 2/1.  49 y/o previously healthy female who had a COVID 19 exposure ~ 1/3. The person she was exposed to tested positive 1/6 (daughter had a fever and cough). On 1/11 the patient received the 1st dose of the Pfizer vaccine. 12-24 hours after the Pfizer vaccine she developed fevers, malaise, myalgias that lasted 2-3 days (Called off work). She then returned to a normal state of health. On 2/1 she received the second dose of the vaccine. On 2/6 she developed right pleuritic chest pain so went to an urgent care. COVID 19 PCR was positive and CXR unremarkable. She was told to take naproxen and her pleuritic chest pain slowly improved. On 2/8 she started to have general malaise followed by nausea. On 2/11 she developed increased nausea and vomiting followed by diarrhea-eventually that day she had a near syncopal episode prompting her presentation to the hospital. Seen at an outside hospital between 2/11-2/12. CT abd/pelvis showed patchy ground glass opacities at the base of the lungs and she was noted to have diffuse mural thickening. There was concern for possible cholecystitis so a perc cholecystostomy tube was placed. Ultimately she developed significant hypoxic respiratory failure and had to be intubated.She was transferred to another hospital on 2/12. Initially she was started on treatment with dexamethasone but continued to clinically get worse. Also on empiric antibiotics.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Anion gap increased, Blood potassium decreased, Dehydration, Feeding disorder, Gastritis
Clinical narrative: Nausea and vomiting as well as cramping that lead to being unable to eat for a week. After a week passed, was admitted to hospital for dehydration and to make sure GI problems were nothing more serious
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Metabolic function test, Muscle spasms, Nausea, Oesophagogastroduodenoscopy abnormal, Vomiting
Clinical narrative: Nausea and vomiting as well as cramping that lead to being unable to eat for a week. After a week passed, was admitted to hospital for dehydration and to make sure GI problems were nothing more serious
Age: 87.0
Sex: F
Vaccine: COVID19
Symptoms: Gait disturbance, Muscle strain, Pain in extremity
Clinical narrative: Forty minutes after second shot, I got a bad pain in the back of my upper right thigh.  I had to limp to my apartment.  I didn't think it could be related to the vaccine as it was so soon, and only in the one place.  It had lasted until now and I've had three physical therapy visits so far, though it is not as bad, but it's over three weeks.  I didn't think it could be related until my doctor's office said they had four cases of the exact same thing, and in younger people. (20's and 30's).  At first, the PT said it was due to a pulled muscle, though I had done nothing at all to account for that.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: Patient received vaccine at 0935 and reported approximately 10 minutes after vaccine experienced itching to arms and face, progressing to the Bilateral arms and back.  Alerted observation staff @ 25 minutes and patient was taken to the first aid station.   Patient denies any SOB, Swelling, no CP and Patient is A & O x 3, VSS at B/P 1238/76, HR 76, RR 18, SaO2 at 95% on RA.   1025-Itching had improved.  1030-B/P 126/68, HR 80, RR 16, SaO2:96% on RA.   1045-Itching improved but residual itching continues-repeated Benadryl 25mg Oral liquid.  11:00-Observed patient for 45 minutes and discharged patient after itching had improved with instructions for the patient to follow up with PCP.  Patient communicated understanding and had no further question prior to discharge home today.   1019- Patient given Benadryl 25 mg Oral liquid.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Biopsy skin normal, Condition aggravated, Seborrhoeic keratosis, Skin discolouration
Clinical narrative: 36 Hours following the vaccine shot, I noticed a number of dark spots under my arms and on my back. A trip to the Dermatologist on Monday 2/15/2021 determined that the vaccine had caused most if not all of the Seborrheic Keratoses (SK's) skin growths on my body to change color to a blue color. Four or the SK's were removed and sent to the lab for biopsy. The result came back as irritated SK's but no mention was made of the discoloration. After one week Friday (2/19), the blue color began to fade and by Sunday (2/20) the smaller of the SK's had returned to their original color while the larger still retain some of the blue color. During this time I felt fine.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Myalgia, Pain, Pain in extremity
Clinical narrative: Within a couple of hours, my arm was sore. About 24 hours later - body aches, chills, muscle aches and fatigue and that was gone the following the day and the arm soreness was gone the following day.
Age: 42.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chest discomfort, Cough, SARS-CoV-2 test negative
Clinical narrative: 1st vaccine 1/22/21; 2nd vaccine 2/12/21; developed cough and chest tightness onset 2/25/21 and seen at ICC same day; was COVID tested at ICC negative
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Dysphagia, Pharyngeal swelling
Clinical narrative: Throat Swelling / Difficulty Swallowing